12 January 2021 A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors. View PDF
Recent News Press Release – First ever UK Neuroendocrine Cancer Specific Nurse Competency Framework receives RCN Accreditation NCUK Research Grant 2021 – application now open! Taking a closer look at NETTER-1 OS – expert-led webinar on 12th July ESE Young Endocrinologists and Scientists (EYES) Virtual NETs for Newcomers day a great success!
Sign up for our newsletterSign-up for our email newsletter. Simply give us your email address in the box below to sign-up.Email
